Pennsylvania is quickly emerging as a national leader in the life sciences sector. From major convention floors in Boston to local biotech labs in Malvern, the Commonwealth is showcasing its strength in life sciences Pennsylvania and life sciences PA. Here’s a look at the momentum building across government, industry, and education.
Governor Shapiro Champions Growth at BIO 2025
Governor Shapiro speaking at a panel at BIO 2025 in Boston
At the BIO 2025 International Convention in Boston on June 17, 2025, Governor Josh Shapiro delivered a compelling message: Pennsylvania is “open for biotech business”. In a fireside chat with BIO’s CEO, he spotlighted key anchors of life sciences Pennsylvania:
-
A proposed $50 million PA Innovation Fund, with $30 million earmarked to spur life‑science job growth and $20 million for broader innovation .
-
Tax credits, workforce funding, R&D grants (especially for neurodegenerative disease research), and accelerated business tax cuts.
An existing powerhouse ecosystem: over 3,100 firms, 100,000+ jobs in life sciences PA**,** and more than 10,700 patents within five years—the fourth-highest total in the nation.
Biotech Across America Tour: Pennsylvania in Focus
U.S. Rep. Chrissy Houlahan (PA‑06) joined the National Security Commission on Emerging Biotechnology (NSCEB) for the “Biotech Across America” tour, spotlighting growing biotech hubs in Malvern and Phoenixville.
-
Events at technical college campuses and a visit to Ocugen—a cutting-edge gene-therapy firm—highlighted the role of life sciences PA in developing next-gen treatments for blindness.
-
Lawmakers emphasized Pennsylvania as a bioindustrial revolution hub, urging stronger venture support to raise its share of national life‑science investment beyond the current 3 % .
NSCEB commissioners praised Pennsylvania as “a blueprint for developing a strong biomanufacturing base,” stressing the need for continued support in biotech and workforce education .
BIOTech Caucus & Precision Medicine Hub
On June 26, 2025, Reps. Houlahan (D‑PA) and Bice (R‑OK) launched the bipartisan BIOTech Caucus, aimed at shaping federal policies around biosecurity, innovation, and workforce development. Key priorities include:
-
Preserving national leadership amid global biotech competition.
-
Streamlining regulations to accelerate commercial breakthroughs.
-
Expanding job opportunities through a robust U.S. bioeconomy.
Regionally, the Greater Philadelphia area received designation as a Precision Medicine Tech Hub, thanks to investments under the CHIPS and Science Act. That marks a major boost in life sciences Pennsylvania, promising thousands of high-quality biotech jobs.
Why This Matters for PA and Beyond
-
Economic Impact & Job Creation: A strengthened life‑science ecosystem could generate 6,500+ new jobs statewide by 2035 .
-
Innovation Pipeline: With clinical trial networks, R&D grants, and venture initiatives, Pennsylvania is closing the loop from lab research to life-saving treatments.
-
National & Global Leadership: Through bipartisan federal action and local political will, the Commonwealth is positioning itself—and the country—as a leader in biotech innovation